Developers in New York are planning to build The World Product Centre, which will be reportedly the world’s first permanent international healthcare marketplace and education center.

December 5, 2008 - CeloNova BioSciences Inc. said this week it expanded the areas in which it is commercializing the CATANIA Coronary Stent System with NanoThin Polyzene-F, a stent system that has not had any stent thrombosis in clinical studies.

It is CE marked and available for purchase throughout Europe and now some Middle Eastern countries. CeloNova has received regulatory approval to increase the shelf life for the stent from two years to three years.

December 5, 2008 - Lebanon County, PA cardiologist Jeffrey L. Williams, M.D., MS, FACC, is the author of a study released in the Journal of Interventional Cardiology, “Feasibility of Myxomatous Mitral Valve Repair Using Direct Leaflet and Chordal Radiofrequency Ablation,” and is said to be the first in the world to describe a completely catheter-based intracardiac ablation approach to repair mitral valve prolapse causing severe mitral regurgitation.

December 5, 2008 – ContextVision introduced its GOPView iRVPlus, a new image enhancement and dose reduction software package for interventional radiology, this week at RSNA 2008 in Chicago.

December 5, 2008 - As the next phase in validating advanced computed tomography technology in a clinical setting, Toshiba Medical Systems Corp. will support CORE 320, the largest worldwide multi-center trial comparing the effectiveness of 320-detector row dynamic volume CT to SPECT technology in cardiac evaluation.

December 4, 2008 - Medical imaging company Barco is expanding its portfolio of medical displays this week at RSNA with a brand-new family of clinical review displays - the MDRC will provide a quality, budget-friendly visualization solution for a wide spectrum of applications throughout hospitals.

December 4, 2008 - A first-ever 208-person study comparing the renal safety, occurrence of cardiovascular adverse events and diagnostic image quality of GE Healthcare's isosmolar contrast media (CM) iodixanol (Visipaque) and the low-osmolar CM iopromide in select patients concluded iodixanol is associated with lower incidence of contrast-induced neuropathy (CIN) and cardiovascular events (CV) than

December 4, 2008 - A first-ever 208-person study comparing the renal safety, occurrence of cardiovascular adverse events and diagnostic image quality of GE Healthcare's isosmolar contrast media (CM) iodixanol (Visipaque) and the low-osmolar CM iopromide in select patients concluded iodixanol is associated with lower incidence of contrast-induced neuropathy (CIN) and cardiovascular events (CV) than iopromide, when used in patients with chronic kidney disease.

December 4, 2008 - St. Jude Medical Inc. this week said it received expanded approval from the Japanese Ministry of Health, Labour and Welfare for the QuickOpt Timing Cycle Optimization feature in the Epic HF and Atlas HF cardiac resynchronization therapy defibrillators (CRT-Ds).

December 4, 2008 - Pressure Products Inc. said this week the FDA granted market clearance to distribute the SafeSept transseptal guide wire, to be used in conjunction with a standard Brockenbrough transseptal needle when performing a transseptal crossing in the setting of atrial fibrillation and other invasive and electrophysiological atrial bi-chamber cardiology procedures.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now